Unknown

Dataset Information

0

Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection.


ABSTRACT: We previously showed that in mice infected with Leishmania major type I interferons (IFNs) initiate the innate immune response to the parasite at day 1 and 2 of infection. Here, we investigated which type I IFN subtypes are expressed during the first 8?weeks of L. major infection and whether type I IFNs are essential for a protective immune response and clinical cure of the disease. In self-healing C57BL/6 mice infected with a high dose of L. major, IFN-?4, IFN-?5, IFN-?11, IFN-?13, and IFN-? mRNA were most prominently regulated during the course of infection. In C57BL/6 mice deficient for IFN-? or the IFN-?/?-receptor chain 1 (IFNAR1), development of skin lesions and parasite loads in skin, draining lymph node, and spleen was indistinguishable from wild-type (WT) mice. In line with the clinical findings, C57BL/6 IFN-?-/-, IFNAR1-/-, and WT mice exhibited similar mRNA expression levels of IFN-?, interleukin (IL)-4, IL-12, IL-13, inducible nitric oxide synthase, and arginase 1 during the acute and late phase of the infection. Also, myeloid dendritic cells from WT and IFNAR1-/- mice produced comparable amounts of IL-12p40/p70 protein upon exposure to L. major in vitro. In non-healing BALB/c WT mice, the mRNAs of IFN-? subtypes (?2, ?4, ?5, ?6, and ?9) were rapidly induced after high-dose L. major infection. However, genetic deletion of IFNAR1 or IFN-? did not alter the progressive course of infection seen in WT BALB/c mice. Finally, we tested whether type I IFNs and/or IL-12 are required for the prophylactic effect of CpG-oligodesoxynucleotides (ODN) in BALB/c mice. Local and systemic administration of CpG-ODN 1668 protected WT and IFN-?-/- mice equally well from progressive leishmaniasis. By contrast, the protective effect of CpG-ODN 1668 was lost in BALB/c IFNAR1-/- (despite a sustained suppression of IL-4) and in BALB/c IL-12p35-/- mice. From these data, we conclude that IFN-? and IFNAR1 signaling are dispensable for a curative immune response to L. major in C57BL/6 mice and irrelevant for disease development in BALB/c mice, whereas IL-12 and IFN-? subtypes are essential for the disease prevention by CpG-ODNs in this mouse strain.

SUBMITTER: Schleicher U 

PROVIDER: S-EPMC5807663 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of <i>Leishmania major</i>, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary <i>L. major</i> Infection.

Schleicher Ulrike U   Liese Jan J   Justies Nicole N   Mischke Thomas T   Haeberlein Simone S   Sebald Heidi H   Kalinke Ulrich U   Weiss Siegfried S   Bogdan Christian C  

Frontiers in immunology 20180205


We previously showed that in mice infected with <i>Leishmania major</i> type I interferons (IFNs) initiate the innate immune response to the parasite at day 1 and 2 of infection. Here, we investigated which type I IFN subtypes are expressed during the first 8 weeks of <i>L. major</i> infection and whether type I IFNs are essential for a protective immune response and clinical cure of the disease. In self-healing C57BL/6 mice infected with a high dose of <i>L. major</i>, IFN-α4, IFN-α5, IFN-α11,  ...[more]

Similar Datasets

| S-EPMC4238992 | biostudies-literature
| PRJNA624043 | ENA
| PRJNA168505 | ENA
| PRJNA311056 | ENA
| PRJNA105077 | ENA
| PRJNA9528 | ENA
| PRJNA311271 | ENA
| PRJNA242762 | ENA
| PRJNA788482 | ENA
| PRJNA110061 | ENA